ic7b02897_si_001.pdf (2.36 MB)
A Copper(II) Nitrite That Exhibits Change of Nitrite Binding Mode and Formation of Copper(II) Nitrosyl Prior to Nitric Oxide Evolution
journal contribution
posted on 2018-01-20, 17:31 authored by Ram Chandra Maji, Saikat Mishra, Anirban Bhandari, Ravindra Singh, Marilyn M. Olmstead, Apurba K. PatraThe proton-coupled
reduction of CuII-bound nitrite (NO2–) to nitric oxide (NO2– + 2H+ + e– → NO(g) + H2O), such as
occurs in the enzyme copper nitrite reductase, is investigated in
this work. Our studies focus on the copper(II/I) model complexes [(L2)Cu(H2O)Cl] (1), [(L2)Cu(ONO)] (2), [(L2)Cu(CH3CO2)] (3), and [Co(Cp)2][(L2)Cu(NO2)(CH3CN] (4), where
HL2 = N-[2-(methylthio)ethyl]-2′-pyridinecarboxamide.
Complex 1 readily reacts with a NO2– anion to form the nitrito-O-bound copper(II) complex 2. Electrochemical reduction of CuII → CuI indicates coordination isomerization from asymmetric nitrito-κ2-O,O to nitro-κ1-N. Isolation and spectroscopic
characterization of 4 support this notion of nitrite
coordination isomerization (νCu–N ∼
460 cm–1). A reduction of 2, followed
by reaction with acetic acid, causes evolution of stoichiometric NO
via the transient copper(II) nitrosyl species and subsequent formation
of the acetate-bound complex 3. The probable copper nitrosyl
intermediate [(L2)Cu(NO)(CH3CN)]+ of the {CuNO}10 type is evident from low-temperature UV–vis absorption
(λmax = 722 nm) and electron paramagnetic resonance
spectroscopy. A density functional theory (DFT)-optimized model of
[(L2)Cu(NO)(CH3CN)]+ shows end-on NO binding
to Cu with Cu–N(NO) and N–O distances of 1.989 and 1.140
Å, respectively, and a Cu–N–O angle of 119.25°,
consistent with the formulation of CuII-NO•. A spin-state change that triggers NO release is observed. Considering
singlet- and triplet-state electronic configurations of this model,
DFT-calculated νNO values of 1802 and 1904 cm–1, respectively, are obtained. We present here important
mechanistic aspects of the copper-mediated nitrite reduction pathway
with the use of model complexes employing the ligand HL2 and an analogous
phenyl-based ligand, N-[2-(methylthio)phenyl]-2′-pyridinecarboxamide
(HL1).